Rituximab for Aggressive Non-Hodgkin's Lymphomas Relapsing After or Refractory to Autologous Stem Cell Transplantation

Overview of attention for article published in Cancer Journal, September 2002

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 1 X post from an account with 6,734 followers.

Rituximab for aggressive non-Hodgkin’s lymphomas relapsing after or refractory to autologous stem cell transplantat… https://t.co/JaAGkna2Q9

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.